3 Result(s)
within
Paul Morrison
Behavioral Sciences
-
Article
Open AccessConnectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin
Abnormalities in functional brain networks (functional connectome) are increasingly implicated in people at Clinical High Risk for Psychosis (CHR-P). Intranasal oxytocin, a potential novel treatment for the CH...
-
Article
Open AccessAcute oxytocin effects in inferring others’ beliefs and social emotions in people at clinical high risk for psychosis
Social deficits are key hallmarks of the Clinical High Risk for Psychosis (CHR-P) state and of established psychotic disorders, and contribute to impaired social functioning, indicating a potential target for ...
-
Article
Open AccessOxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
Preclinical and human studies suggest that hippocampal dysfunction is a key factor in the onset of psychosis. People at Clinical High Risk for psychosis (CHR-P) present with a clinical syndrome that can includ...
